Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.

Diphencyprone therapy for hair loss can cause vitiligo.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Some vaccines might rarely cause hair loss, more research is needed.

A liver transplant patient with APECED had a rare VZV recurrence and pneumonia, treated successfully, but later died from other infections.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients, but longer follow-up is needed.

Ringworm in cattle can be effectively treated with Povidone iodine and Whitefield ointment.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

The HPV vaccine may be linked to temporary hair loss in children, but the benefits outweigh the risks.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Valette® is an effective birth control pill that also reduces greasy hair and skin.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

Severe COVID-19 often leads to hair loss in India.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

COVID-19 can cause skin problems in children.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

COCs often cause nausea, vomiting, and hair loss, while Depo-Provera is linked to weight gain.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Using cidofovir cream for a rare skin disease can cause skin darkening.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.